Gritstone Bio Says Early Progression-Free Survival Trends Favor GRANITE Recipients With Hazard Ratios Of 0.82 In The Overall Population And 0.52 In A High-Risk Group, Where Clinical Data Are More Mature
Gritstone Bio Says Early Progression-Free Survival Trends Favor GRANITE Recipients With Hazard Ratios Of 0.82 In The Overall Population And 0.52 In A High-Risk Group, Where Clinical Data Are More Mature
Gritstone Bio表示，早期无进展存活趋势有利于GRANITE接受者，总人群的危害比为0.82，高风险人群的危害比为0.52，临床数据更为成熟
Gritstone Bio Says Early Progression-Free Survival Trends Favor GRANITE Recipients With Hazard Ratios Of 0.82 In The Overall Population And 0.52 In A High-Risk Group, Where Clinical Data Are More Mature
Gritstone Bio表示，早期无进展存活趋势有利于GRANITE接受者，总人群的危害比为0.82，高风险人群的危害比为0.52，临床数据更为成熟
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。